AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2021
Jun 17, 2021
29821_dirs_2021-06-17_a26080c7-b8e9-4476-afaf-6f8ce561bc18.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-06-07
Reporting Person: Brown Vance R (SVP, GC and Corp. Secretary)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 27436.0000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Deferred Stock Units | $ | 2023-02-15 | Common Stock (1846.0000) | Direct | |
| Deferred Stock Units | $ | 2024-02-18 | Common Stock (2223.0000) | Direct | |
| Deferred Stock Units | $ | 2023-02-21 | Common Stock (1558.0000) | Direct | |
| Deferred Stock Units | $ | 2022-02-28 | Common Stock (1019.0000) | Direct | |
| Deferred Stock Units | $ | 2022-10-02 | Common Stock (6787.0000) | Direct | |
| Restricted Stock Units | $ | 2025-02-17 | Common Stock (4000.0000) | Direct | |
| Stock Option (Right to Buy) | $24.5500 | 2027-02-28 | Common Stock (18037.0000) | Direct | |
| Stock Option (Right to Buy) | $27.0900 | 2028-02-15 | Common Stock (15006.0000) | Direct | |
| Stock Option (Right to Buy) | $37.5000 | 2031-02-17 | Common Stock (14299.0000) | Direct | |
| Stock Option (Right to Buy) | $40.1200 | 2029-02-21 | Common Stock (10757.0000) | Direct | |
| Stock Option (Right to Buy) | $42.1600 | 2030-02-18 | Common Stock (12030.0000) | Direct |
Footnotes
F1: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
F2: This amount represents the unvested portion of DSUs awarded on February 15, 2018, which will continue to vest in two remaining installments on the anniversary of the date of grant.
F3: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
F5: This amount represents the unvested portion of DSUs awarded on February 28, 2020, which will continue to vest in three remaining installments on the anniversary of the date of grant.
F6: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
F7: This amount represents the unvested portion of DSUs awarded on February 21, 2019, which will continue to vest in two remaining installments on the anniversary of the date of grant.
F8: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
F9: This amount represents the unvested portion of DSUs awarded on February 28, 2017, which will continue to vest in one remaining installment on the anniversary of the date of grant.
F10: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on October 2, 2018, the first anniversary of the date of grant.
F11: This amount represents the unvested portion of DSUs awarded on October 2, 2017, which will continue to vest in two remaining installments on the anniversary of the date of grant.
F12: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F13: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F14: Grant to the reporting person of an option to purchase 18,037 shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
F15: Grant to the reporting person of an option to purchase 15,006 shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
F16: Grant to the reporting person of an option to purchase 14,299 shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F17: Grant to the reporting person of an option to purchase 10,757 shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
F18: Grant to the reporting person of an option to purchase 12,030 shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.